Zobrazeno 1 - 10
of 203
pro vyhledávání: '"K. Karmiris"'
Autor:
N. Viazis, I. Drygiannakis, K. Karmiris, A. Theodoropoulou, E. Zampeli, M. Tzouvala, G. Bamias, C. Liatsos, G. Theocharis, S. Vrakas, E. Tsironi, N. Mathou, A. Mantaka, A. Christidou, K. Koustenis, Ch. Veretanos, E. Papathanasiou, E. Zacharopoulou, G. Tribonias, V. Kitsou, S. Kartsoli, A. Theodoulou, S. Michopoulos, K. Thomopoulos, I.E. Koutroubakis, G.J. Mantzaris
Publikováno v:
Digestive and Liver Disease. 55:305-309
Autor:
K Foteinogiannopoulou, P Nicolaou, A Mala, E Theodoraki, E Orfanoudaki, A Theodoropoulou, K Karmiris, I Koutroubakis
Publikováno v:
Journal of Crohn's and Colitis. 17:i896-i899
Background There is evidence that about 30% of the patients with inflammatory bowel disease (IBD) develop malignancies whichconstitute the second cause of death, after cardiovascular diseases, such as in general population. Methods The aim of this st
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Background/Aim: Primary mediastinal large Bcell lymphoma (PMLBCL) is an aggressive B-cell non- Hodgkin lymphoma (NHL), whose prognosis has greatly improved since the incorporation of the anti-CD20 monoclonal antibody rituximab into current therapeuti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::aac0fd8434bc5524bf5c24e52f2d534c
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3219445
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3219445
Autor:
E Zacharopoulou, E Orfanoudaki, V Kitsou, M Tzouvala, G Tribonias, G J Mantzaris, N Viazis, A Christidou, F Almpani, K Karmiris, A Theodoropoulou, M Tsafaridou, S Michopoulos, E Zampeli, E Papathanasiou, G Michalopoulos, S Tigkas, P Karatzas, E Laoudi, C Liatsos, N Kyriakos, I Mylonas, G Theocharis, I E Koutroubakis, G Bamias
Publikováno v:
Journal of Crohn's and Colitis. 16:i581-i582
Background The novel corona virus (SARS-CoV-2) outbreak was declared as a pandemic in March 2020; this prompted the need for rapid vaccine development. Currently four EMA approved vaccines exist but their efficacy and safety data on patients with Inf
Autor:
E Orfanoudaki, E Zacharopoulou, V Kitsou, K Karmiris, A Theodoropoulou, G J Mantzaris, M Tzouvala, S Michopoulos, E Zampeli, G Michalopoulos, P Karatzas, N Viazis, C Liatsos, G Bamias, I E Koutroubakis
Publikováno v:
Journal of Crohn's and Colitis. 16:i576-i577
Background Since inflammatory bowel disease (IBD) patients were excluded from vaccine authorization studies, limited knowledge exists regarding perceptions for and unfavorable effects of COVID-19 vaccination in this group. The aim of this study was t
Autor:
N Viazis, A Theodoropoulou, E Zampeli, K Karmiris, M Tzouvala, G Bamias, I Koutroubakis, C Liatsos, K Koustenis, C Veretanos, E Papathanasiou, E Zacharopoulou, G Tribonias, V Kitsou, I Drygiannakis, S Michopoulos, G Mantzaris
Publikováno v:
Journal of Crohn's and Colitis. 16:i283-i284
Background Patients with Inflammatory Bowel Disease (IBD), especially those on immunosuppressive (IMS) treatment should be vaccinated against SARS-CoV-2 to prevent hospitalization, mechanical ventilation, and death. However, IMS may adversely affect
Purpose: To study the effects of mean apnea–hypopnea duration (MAD), a useful indicator of blood oxygenation, on peripapillary retinal nerve fiber layer (RNFL), macular ganglion cell to inner plexiform layer (GC-IPL) and macular retinal thickness i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::04c36b1bd0aaec78391a6dd5a29ce1a8
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3119980
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3119980